Furthermore, patients initiated with a short acting insulin regimen as a component of premixed insulin may need to be highly vigilant and motivated to recognize the symptoms of hypoglycemia, and they required to be adherent with the medications and its administration techniques as well as the dosing. This evidence concerns the gene INS and Hypoglycemia.